These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17127564)

  • 1. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.
    Sorarù G; Pegoraro E; Spinella P; Turra S; D'Ascenzo C; Baggio L; Mantovan MC; Vergani L; Angelini C
    Amyotroph Lateral Scler; 2006 Dec; 7(4):246-8. PubMed ID: 17127564
    [No Abstract]   [Full Text] [Related]  

  • 2. Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.
    Brooks BR; Juhasz-Poscine K; Waclawik A; Sanjak M; Belden D; Roelke K; Parnell J; Weasler C
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():45-53; discussion 53-4. PubMed ID: 11466959
    [No Abstract]   [Full Text] [Related]  

  • 3. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect].
    Puls I; Beck M; Giess R; Magnus T; Ochs G; Toyka KV
    Nervenarzt; 1999 Dec; 70(12):1112-5. PubMed ID: 10637819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies].
    Oya Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2001 Oct; 41(10):698-700. PubMed ID: 11993192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clenbuterol impairs muscle quality and is potentially dangerous.
    Habedank D; Steeg M; Anker SD
    J Heart Lung Transplant; 2008 Aug; 27(8):934-5. PubMed ID: 18656813
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol (author's transl)].
    Grüneberger A; Geier G
    Urologe A; 1981 May; 20(3):153-4. PubMed ID: 6115496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clenbuterol: 'redistribution agent'].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1782-5. PubMed ID: 2903453
    [No Abstract]   [Full Text] [Related]  

  • 10. Clenbuterol and the horse revisited.
    Kearns CF; McKeever KH
    Vet J; 2009 Dec; 182(3):384-91. PubMed ID: 18926742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.
    Kamalakkannan G; Petrilli CM; George I; LaManca J; McLaughlin BT; Shane E; Mancini DM; Maybaum S
    J Heart Lung Transplant; 2008 Apr; 27(4):457-61. PubMed ID: 18374884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyotrophic lateral sclerosis. Clinical evaluation and therapeutic response to ara-A].
    Chimpen Ruiz V; Sánchez Rodríguez A; García Legido A; Pascual González F; Fermoso García J; de Portugal Alvarez J
    Rev Clin Esp; 1984 May; 173(4):223-5. PubMed ID: 6484249
    [No Abstract]   [Full Text] [Related]  

  • 13. Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study.
    Sanjak M; Bravver E; Bockenek WL; Norton HJ; Brooks BR
    Arch Phys Med Rehabil; 2010 Dec; 91(12):1920-9. PubMed ID: 21112435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy of amyotrophic lateral sclerosis].
    Jokelainen M
    Duodecim; 1997; 113(6):513-6. PubMed ID: 11370073
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot trial of clenbuterol in spinal and bulbar muscular atrophy.
    Querin G; D'Ascenzo C; Peterle E; Ermani M; Bello L; Melacini P; Morandi L; Mazzini L; Silani V; Raimondi M; Mandrioli J; Romito S; Angelini C; Pegoraro E; Sorarù G
    Neurology; 2013 Jun; 80(23):2095-8. PubMed ID: 23645595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis.
    Adams S; Isaacs J
    J Hand Surg Am; 2010 May; 35(5):844-5; quiz 845. PubMed ID: 19942362
    [No Abstract]   [Full Text] [Related]  

  • 17. Diaphragm training in amyotrophic lateral sclerosis.
    Nardin R; O'Donnell C; Loring SH; Nie R; Hembre K; Walsh J; Arboleda BW; Muzikansky A; Nguyen D; Raynor E
    J Clin Neuromuscul Dis; 2008 Dec; 10(2):56-60. PubMed ID: 19169091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?
    Lindhorst S; Cudkowicz M
    Nat Clin Pract Neurol; 2006 Jul; 2(7):364-5. PubMed ID: 16932586
    [No Abstract]   [Full Text] [Related]  

  • 19. Clenbuterol-contaminated heroin: cardiovascular and metabolic effects. A case series and review.
    Werder G; Arora G; Frisch A; Aslam S; Imani F; Missri J
    Conn Med; 2006 Jan; 70(1):5-11. PubMed ID: 16479869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Injury claim in the administration of clenbuterol-containing drugs].
    van der Weg CP
    Tijdschr Diergeneeskd; 1996 Jul; 121(13):394-5. PubMed ID: 8711717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.